Search filters

List of works by Corrado Ficorella

"Palliative" or "Supportive": Is It Just a Matter of Word?

scientific article published on 01 November 2018

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study.

scientific article

"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer.

scientific article

A case of segmental hepatic necrosis complicating oxaliplatin and capecitabine chemotherapy A case report and review of the literature

scientific article published on 28 September 2020

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

scientific article published on 27 February 2019

A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients

scientific article published on 01 October 2020

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

scientific article published on 25 May 2017

Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen.

scientific article published in March 2002

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-r

scientific article published on 04 February 2020

Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib

scientific article published on 28 March 2011

Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line.

scientific article published on January 2004

Assessment and treatment of symptoms among Italian medical oncologists

scientific article published on 29 April 2005

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

scientific article published on 01 October 2020

Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer.

scientific article published on 15 April 2016

Can malignant bowel obstruction in advanced cancer patients be treated at home?

scientific article published on 25 September 2010

Cancer Care After Natural Disaster: Different Countries, Similar Problems

scientific article published on 01 July 2019

Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.

scientific article published in March 2006

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

scientific article published on 22 October 2020

Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes

scientific article published on 22 August 2020

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

scientific article published on 22 February 2019

Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors

scientific article published on 08 June 2019

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50

scientific article published on 30 May 2020

Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines.

scientific article published on 5 November 2013

Comment on 'What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion'.

scientific article published in July 2016

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

scientific article published on 30 November 2018

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

scientific article published on 02 October 2018

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified Mutation

article

Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, FIr-B/FOx, according to second-line treatment and KRAS genotype

scientific article

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

scientific article published on 07 August 2019

Does pain intensity predict a poor opioid response in cancer patients?

scientific article

Dose-dense nonpegylated liposomal Doxorubicin and docetaxel combination in breast cancer: dose-finding study

scientific article

Dose-finding study of oxaliplatin associated to capecitabine-based preoperative chemoradiotherapy in locally advanced rectal cancer.

scientific article published on 3 April 2018

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

scientific article

EGFR genomic alterations in cancer: prognostic and predictive values

scientific article published on June 2011

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

scientific article published on 15 November 2019

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

scientific article published on 16 November 2020

Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients?

scientific article published on 20 August 2007

Effectiveness and safety of intensive triplet chemotherapy plus bevacizumab, FIr-B/FOx, in young-elderly metastatic colorectal cancer patients

scientific article published on 6 November 2013

Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab

scientific article published on 27 December 2011

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

scientific article published on 20 April 2013

Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro.

scientific article

Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study

scientific article published on 3 April 2009

Efficacy of Treatment With Tetracyclines to Prevent Acneiform Eruption Secondary to Cetuximab Therapy

scientific article published in September 2005

Efficacy of pregabalin in the management of cetuximab-related itch

scientific article published on 01 November 2006

Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer

scientific article published in November 2009

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

scientific article published on 07 January 2020

Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer

scientific article published on 30 August 2020

Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study

scientific article published on 16 May 2020

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

scientific article published on 07 August 2018

Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer

scientific article published on 06 April 2020

Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study

scientific article published on 06 July 2020

Family history of cancer and DNA damage response genes: Two sides of the same coin?

scientific article published on 08 December 2018

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study

scientific article published on 22 March 2018

Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience.

scientific article published in July 2010

Gabapentin in the treatment of severe sweating experienced by advanced cancer patients.

scientific article published on 10 January 2006

Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series

scientific article published on 24 March 2020

Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment

scientific article

Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases.

scientific article published on 26 September 2003

High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis

scientific article published on 01 September 2002

Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit

article

Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.

scientific article published on 24 March 2014

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab

scientific article published on 01 December 2018

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

scientific article published on 21 June 2020

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

scientific article published on 15 January 2020

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study

scientific article published on 01 February 2020

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

scientific article published on 15 October 2019

In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells

scientific article published in April 2004

Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer.

scientific article published on 23 May 2016

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

scientific article published on 01 November 2020

Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit

scientific article published on March 2013

Integration between oncology and palliative care: a plan for the next decade?

scientific article published on 12 May 2017

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GI

scientific article published on 17 April 2019

Is it possible to teach pain therapy playing basketball?

scientific article published on 01 January 2016

Is there a role for neurologist in an oncological home care team?

scientific article

KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease.

scientific article published on 30 January 2018

Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law.

scientific article published in September 2017

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

scientific article published on 23 May 2020

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation

scientific article published on 22 January 2019

Low doses of transdermal fentanyl in opioid-naive patients with cancer pain

scientific article

Low morphine doses in opioid-naive cancer patients with pain

scientific article published in March 2006

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer

scientific article

Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer

scientific article

Morphine in the treatment of incident pain triggered by vinorelbine infusion

scientific article published on 22 January 2008

Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A "snapshot" from clinical practice.

scientific article published on 7 December 2017

Multidisciplinary management of hepatocellular carcinoma in clinical practice

scientific article

Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future

scientific article published on 11 September 2020

Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations.

scientific article

New mutations and protein variants of NBS1 are identified in cancer cell lines

scientific article published on 01 February 2003

New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting

scientific article published on 15 July 2016

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids.

scientific article published on 17 April 2013

P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer

scientific article published in January 2003

Pain characteristics and analgesic treatment in an aged adult population: a 4-week retrospective analysis of advanced cancer patients followed at home.

scientific article published on April 2015

Pain evaluation and management: a survey of Italian radiotherapists

scientific article published on 09 October 2004

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

scientific article published on 10 December 2018

Palliative care in advanced cancer patients: how and when? And where?

scientific article published on 17 May 2012

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study

scientific article published on 13 December 2019

Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer

scientific article published on 3 August 2009

Physical exercise and quality of life in breast cancer survivors

scientific article

Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma

scientific article published on 23 June 2020

Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report

scientific article published on 02 January 2019

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study ⬇️

journal article from 'The Lancet Oncology' published in 2021

Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence

scientific article published on 22 May 2015

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

scientific article published on 06 February 2020

Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen

scientific article

Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis

scientific article published on 16 June 2017

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

scientific article

Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.

scientific article published on 26 January 2019

Rapid resolution of refractory chemotherapy-induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report

scientific article published on 15 August 2014

Rare bone toxicity associated with vismodegib

scientific article published on 04 May 2020

Re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey"

scientific article published on 22 November 2016

Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma

scientific article

Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies

scientific article published on 24 April 2013

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome.

scientific article

Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis

scientific article published on 10 February 2019

Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy

scientific article published on 27 September 2018

Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings

scientific article published on 23 August 2015

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

scientific article

Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine

scientific article

Tapentadol in cancer pain management: a prospective open-label study

scientific article published on 26 October 2012

The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study

scientific article published on 24 May 2018

The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings

scientific article published on 01 February 2020

The Supportive Care Task Force at the University of L'Aquila: 2-years experience

scientific article published on 23 February 2005

The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A 'hypothesis-generator' study from clinical practice

scientific article published on 10 October 2018

The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens?

scientific article published on 16 October 2014

The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference

scientific article published on 07 May 2020

The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting

scientific article published on 7 April 2013

Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer

scientific article

Timed‑flat infusion of 5‑fluorouracil with docetaxel and oxaliplatin as first‑line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen

scientific article published on 06 June 2018

Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy.

scientific article published on July 2017

Topical morphine in the treatment of painful ulcers.

scientific article published in October 2005

Triplet chemotherapy in patients with metastatic colorectal cancer: toward the best way to safely administer a highly active regimen in clinical practice.

scientific article published on 12 June 2012

Weekly administration of paclitaxel: theoretical and clinical basis

scientific article

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

scientific article published on 25 March 2019

Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

scientific article published on 29 January 2020

Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study

scientific article published on 06 July 2019

What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes

scientific article published on 01 May 2019

Where are we with treatment options after first line in small cell lung cancer?-report of two opposite cases treated with CAPTEM regimen and possible perspectives.

scientific article published in July 2018

Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)

scientific article

Paulina is supported by:

About Paulina

Help